Efficacy and safety of cinacalcet compared with other treatments for secondary hyperparathyroidism in patients with chronic kidney disease or end-stage renal disease: a meta-analysis

Overview of attention for article published in BMC Nephrology, July 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 20 X posts from 20 X users, with an upper bound of 50,533 followers.

RT @JonathanNefro: CINACALCET en enfermedad renal crónica e HIPERPARATIROIDISMO secundario: •PTHi -259pg/mL •calcio -0.92mg/dL •fosfato -0…

RT @JonathanNefro: CINACALCET en enfermedad renal crónica e HIPERPARATIROIDISMO secundario: •PTHi -259pg/mL •calcio -0.92mg/dL •fosfato -0…

RT @JonathanNefro: CINACALCET en enfermedad renal crónica e HIPERPARATIROIDISMO secundario: •PTHi -259pg/mL •calcio -0.92mg/dL •fosfato -0…

RT @JonathanNefro: CINACALCET en enfermedad renal crónica e HIPERPARATIROIDISMO secundario: •PTHi -259pg/mL •calcio -0.92mg/dL •fosfato -0…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 16 additional X posts.